# Healthetech, Inc. SMART Study

> **NCT00194194** · PHASE2 · COMPLETED · sponsor: **Temple University** · enrollment: 56 (actual)

## Conditions studied

- Moderate Behavior Management
- Intensive Behavior Management

## Interventions

- **BEHAVIORAL:** moderate
- **DEVICE:** Resting Metablic Rate measurements

## Key facts

- **NCT ID:** NCT00194194
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2009-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194194, "Healthetech, Inc. SMART Study". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00194194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
